This course will be delivered in two parts:
- Part 1 consists of a recommended pre reading and a 1-hour eLearning component on advanced liver disease.
- Part 2 consist of two live online Zoom training sessions building on the pre reading and eLearning content through presentations and practical case discussions.
Please note that you will need to attend both of the live Zoom sessions in order to receive a certificate of completion.
- Session 1: 10 am-1 pm (AEDT), Friday 26 November
- Session 2: 10 am-1 pm (AEDT), Friday 3 December
Target audience
Nurses working in sexual health services, public and private medical clinics, refugee and migrant services, correctional facilities, Aboriginal and Torres Strait Islander health services, drug and alcohol services, mental health services, and youth services, and midwives nationally .
Learning objectives
By the end of this training, participants will be able to:
- Describe risk factors for HCV, enabling discussions with patients around prevention
- Discuss HCV serology to identify opportunities for screening, testing and linkage-to-care
- Explain the nurse’s role in providing culturally appropriate care, free from stigma and discrimination, to people from priority populations
- Explain the nurse’s role in the management of chronic HCV, advanced liver disease and hepatocellular carcinoma
- Outline strategies for supporting patients with medication adherence
- Describe risk factors for HCV, enabling discussions with patients around prevention
Learning objectives align with the AHA Practice Standards for the Hepatology Nurse (2015) and the AHA Consensus based Nursing Guidelines (2019). The course is also endorsed by the Australian Liver Association.
Accreditation
This course is endorsed by the ACN according to its Continuing Professional Development (CPD) Endorsed Course Standards. It has been allocated 6.5 CPD Hours according to the Nursing and Midwifery Boards of Australia – Continuing Professional Development Standard.